SYDNEY, AUSTRALIA: BCAL Diagnostics Limited (ASX:BDX) has announced the appointment of Shane Ryan as the new CEO, effective from April 2, 2024. Ryan, previously the company’s COO, will lead the launch of the innovative breast cancer test, BREASTEST™, and drive the company’s commercialisation efforts. Ryan’s extensive experience in biotechnology product commercialisation, notably his successful launch…